Total Payments
$731,728
2024 Payments
$3,840
Companies
12
Transactions
775
Medicare Patients
250
Medicare Billing
$59,318
Payment Breakdown by Category
Other$418,186 (57.2%)
Consulting$212,860 (29.1%)
Travel$89,086 (12.2%)
Food & Beverage$11,394 (1.6%)
Gifts$154.45 (0.0%)
Education$48.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $416,866 | 153 | 57.0% |
| Consulting Fee | $212,860 | 38 | 29.1% |
| Travel and Lodging | $89,086 | 377 | 12.2% |
| Food and Beverage | $11,394 | 202 | 1.6% |
| Honoraria | $1,320 | 1 | 0.2% |
| Gift | $154.45 | 3 | 0.0% |
| Education | $48.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $216,036 | 325 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $136,256 | 113 | $0 (2022) |
| Janssen Research & Development, LLC | $95,567 | 32 | $0 (2023) |
| Alkermes, Inc. | $90,501 | 88 | $0 (2023) |
| Merck Sharp & Dohme LLC | $84,121 | 98 | $0 (2022) |
| BioXcel Therapeutics, Inc. | $71,376 | 78 | $0 (2024) |
| Eisai Inc. | $16,280 | 19 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $10,108 | 12 | $0 (2021) |
| Allergan Inc. | $9,682 | 5 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $1,728 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,840 | 1 | BioXcel Therapeutics, Inc. ($3,840) |
| 2023 | $86,225 | 89 | BioXcel Therapeutics, Inc. ($67,536) |
| 2022 | $79,255 | 58 | Alkermes, Inc. ($34,686) |
| 2021 | $41,013 | 22 | Janssen Research & Development, LLC ($22,900) |
| 2020 | $24,180 | 18 | Alkermes, Inc. ($10,572) |
| 2019 | $231,428 | 241 | Janssen Pharmaceuticals, Inc ($113,694) |
| 2018 | $124,391 | 145 | Sunovion Pharmaceuticals Inc. ($77,593) |
| 2017 | $141,396 | 201 | Merck Sharp & Dohme Corporation ($77,324) |
All Payment Transactions
775 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/15/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Consulting Fee | Cash or cash equivalent | $3,840.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 12/20/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,375.00 | General |
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,760.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $44.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $26.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | Cash or cash equivalent | $14.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $12.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | Cash or cash equivalent | $11.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | Cash or cash equivalent | $10.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | Cash or cash equivalent | $7.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $2.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $980.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $350.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $69.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $40.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $69.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $26.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Consulting Fee | Cash or cash equivalent | $2,520.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $35.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,320.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 43 | 160 | $26,560 | $12,296 |
| 2022 | 1 | 46 | 174 | $28,884 | $14,196 |
| 2021 | 3 | 76 | 240 | $36,586 | $19,413 |
| 2020 | 3 | 85 | 238 | $30,025 | $13,414 |
Total Patients
250
Total Services
812
Medicare Billing
$59,318
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 160 | $26,560 | $12,296 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 174 | $28,884 | $14,196 | 49.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 179 | $29,522 | $15,681 | 53.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 16 | 29 | $3,480 | $2,001 | 57.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 32 | $3,584 | $1,730 | 48.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 125 | $13,874 | $5,606 | 40.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 63 | $10,251 | $4,389 | 42.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 22 | 50 | $5,900 | $3,419 | 58.0% |
About Sheldon Preskorn, PHD
Sheldon Preskorn, PHD is a Psychiatry healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841252566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sheldon Preskorn, PHD has received a total of $731,728 in payments from pharmaceutical and medical device companies, with $3,840 received in 2024. These payments were reported across 775 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($416,866).
As a Medicare-enrolled provider, Preskorn has provided services to 250 Medicare beneficiaries, totaling 812 services with total Medicare billing of $59,318. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Geriatric Psychiatry
- Location Wichita, KS
- Active Since 04/06/2006
- Last Updated 01/04/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1841252566
Products in Payments
- LATUDA (Drug) $213,720
- SPRAVATO (Drug) $136,155
- BELSOMRA (Drug) $84,121
- IGALMI (Drug) $71,376
- LYBALVI (Drug) $41,319
- Aristada 441 mg (Drug) $22,013
- Dayvigo (Drug) $9,920
- VRAYLAR (Drug) $9,742
- APTIOM (Drug) $2,315
- INVEGA SUSTENNA (Drug) $100.92
- NUPLAZID (Drug) $12.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Wichita
Dr. Dwight St Clair, Do, DO
Psychiatry — Payments: $44,490
Psychiatry $44,490
Dr. Paul Murphy, M.d, M.D
Psychiatry — Payments: $33,828
Psychiatry $33,828
Dr. Ralph Bharati, Md, MD
Psychiatry — Payments: $25,839
Psychiatry $25,839
Heidi Ogden, Md, MD
Psychiatry — Payments: $22,157
Psychiatry $22,157
Dr. Mukhtar Shah, M.d, M.D
Psychiatry — Payments: $13,680
Psychiatry $13,680
Dr. Rex Lear, Md, MD
Psychiatry — Payments: $13,397
Psychiatry $13,397